Arnott C, Li JW, Cannon CP, de Zeeuw D, et al. The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial. Diabetes Obes Metab 2021;23:1652-1659.
PMID: 33769679